a-galactosidase-treated pea-based crackers in patients with FGIDs
In patients with IBS or functional bloating the a-galactosidase treated cracker had no effect on gastrointestinal symptoms, breath hydrogen concentrations or the overall gut microbiota. ClinicalTrials.gov, number NCT05118243.